Indo Borax Pledges 5.19 Million Kronox Lab Shares for Rs 225 Crore Loan

Indo Borax & Chemicals has pledged 5,194,560 equity shares of Kronox Lab Sciences, representing a 14% stake.
The pledge serves as collateral for a Rs 225 crore term loan facility.

Reader Takeaway: Pledging shares is standard for securing large debt, but monitoring future debt-servicing costs remains essential for shareholders.

What just happened

Indo Borax & Chemicals Ltd informed the stock exchanges that on October 19, 2026, it created a formal pledge over more than 5.19 million shares of its subsidiary, Kronox Lab Sciences Limited. This pledged volume accounts for approximately 14% of the subsidiary’s total paid-up equity share capital. The company executed this transaction to provide security for a Rs 225 crore term loan used to finance its acquisition of shares in the subsidiary.

Why this matters

The disclosure provides transparency regarding the company’s capital structure and financing strategy. While pledging shares is a routine mechanism to secure corporate funding, it introduces a layer of debt obligation that the company must service from its cash flows. Shareholders should focus on how this debt will influence the consolidated balance sheet and future liquidity.

What changes now

Indo Borax & Chemicals continues to hold 23,844,000 shares, maintaining a 64.26% majority stake in Kronox Lab Sciences. The company has clarified that the pledge does not constitute a transfer of control or a reduction in its ownership position. Kronox Lab Sciences remains a subsidiary, and daily operations are unaffected by this financial arrangement.

What to track next

Investors should monitor the company’s upcoming quarterly filings for details on interest coverage ratios and the repayment schedule of the Rs 225 crore term loan. Evaluating whether the subsidiary’s performance generates sufficient returns to offset the associated interest costs will be a key performance indicator.